This study aims to explore the clinical characteristics of T-cell large granular lymphocyte leukemia(T-LGLL)patients with STAT3 mutation status and provide a reference for clinical management of such patients. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.